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Introduction
All cause mortality increases with lower levels of esti-
mated glomerular filtration rates. As part of a comorbid-
ity focus, we assessed the eGFR in CSF-flow disorder
patients guided by NICE recommendations, current lit-
erature recognising a relative hazard ratio per 15mls/min
decrease in eGFR of 1.04[1] and consideration of the
2010 Chronic Kidney Disease Epidemiology Collabora-
tion eGFR categories.
Methods
182 CSf-flow disorder patients who had eGFR measure-
ment were grouped into the respective subtypes; IIH
(n=41), NPH (n=72), CSF hypovolaemia (n=7) and other
causes (n=45). Others included those investigated for
NPH but found not to be suitable for shunt.
Estimated GFR was categorised as per NICE guide-
lines; (ml/min/1.73m) in line with current clinical
laboratory facilities;
>90 normal high,






The eGFR’s were recorded and the mean calculated
for each subgroup.
Results
IIH cohort; mean eGFR 77.73;
26 patients >90 normal high, 14 patients in 60-80 mild
reduction, and 1 patient 45-59 mild-moderate category.
Primary NPH; mean eGFR 73.32mls/min; 18 patients
>90 normal high, 35 patients 60-89 mild reduction,
17 patients 45-59 mild-moderate and 2 patients 30-44
moderate-severe category.
Secondary NPH; mean eGFR 81.94mls/min; 16
patients 60-89 mild reduction range and 1 patient 45-59
mild-moderate category.
Orthostatic HA; mean eGFR 87.25mls/min; 5 patients
>90 normal high and 2 patients 60-89 mild reduction.
Other cohort; mean eGFR 76.96mls/min; 22 patients
>90, 21 patients 60-89 mild reduction and 2 patients
45-59 in the moderate-severe reduction.
Of the 182 patients, 71 patients had high normal
eGFRs >90mls/min representing 39% of patients. 48%
fell into the 60-89 mild reduction range, 11.5% into the
45-59 mild-moderate reduction range and 1% into the
moderate-severe reduction range.
Conclusions
A reduced estimated GFR is commonly seen in the CSF-
flow disorders patient cohorts. Given the emphasis
towards comorbidity factors influencing surgical out-
comes, this acts as a marker of comorbidity and physio-
logical reserve for surgical tolerance and post-operative
performance and should therefore be taken into
consideration.
The altered eGFR could represent the comorbid state
of the patient or it could form an element of the under-
lying pathophysiology of CSF-flow disorders or indeed
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both. Larger studies are required with more translational
medical research models.
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